Protara Therapeutics, Inc. Repayments of Short-term Debt
Protara Therapeutics, Inc. (TARA) reported Repayments of Short-term Debt of $1.67 million for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfShortTermDebt · last filed 2022-03-09
- Protara Therapeutics, Inc. repayments of short-term debt for the quarter ending 2020-12-31 was $371.22K.
- Protara Therapeutics, Inc. repayments of short-term debt for the quarter ending 2020-09-30 was $556.19K.
- Protara Therapeutics, Inc. repayments of short-term debt for the quarter ending 2020-06-30 was $370.79K.
- Protara Therapeutics, Inc. repayments of short-term debt for the quarter ending 2020-03-31 was $370.79K.
- Protara Therapeutics, Inc. repayments of short-term debt for fiscal 2020 was $1.67M.
| Period end | Repayments of Short-term Debt 3 month | Repayments of Short-term Debt 6 month | Repayments of Short-term Debt 9 month | Repayments of Short-term Debt 12 month |
|---|---|---|---|---|
| 2020-12-31 | $371.22K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | $927.41K derived: sum of 2 quarters · filed 2022-03-09 | $1.30M derived: sum of 3 quarters · filed 2022-03-09 | $1.67M 10-K · filed 2022-03-09 |
| 2020-09-30 | $556.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $926.98K derived: sum of 2 quarters · filed 2020-11-12 | $1.30M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $370.79K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $741.59K 10-Q · filed 2020-07-31 | ||
| 2020-03-31 | $370.79K 10-Q · filed 2020-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |